Evidence map›Paper›PMID 38861071›Full record

ArticleJournal of imaging informatics in medicine2024

Res-TransNet: A Hybrid deep Learning Network for Predicting Pathological Subtypes of lung Adenocarcinoma in CT Images.

Yue Su, Xianwu Xia, Rong Sun, Jianjun Yuan, Qianjin Hua, Baosan Han, Jing Gong, Shengdong Nie

Abstract read
In one paragraph

Article in Journal of imaging informatics in medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Development and validation of a transformer-based deep learning model for predicting distant metastasis in non-small cell lung cancer usingClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yue Su *School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, 200093, China.
Xianwu Xia *Department of Oncology Intervention, Municipal Hospital Affiliated of Taizhou University, Zhejiang, Taizhou, 318000, China.
Rong SunSchool of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, 200093, China.
Jianjun YuanDepartment of Oncology Intervention, Municipal Hospital Affiliated of Taizhou University, Zhejiang, Taizhou, 318000, China.
Qianjin HuaDepartment of Oncology Intervention, Municipal Hospital Affiliated of Taizhou University, Zhejiang, Taizhou, 318000, China.
Baosan HanSchool of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, 200093, China. hanbaosan@126.com.
Jing GongDepartment of Radiology, Fudan University Shanghai Cancer Center, 270 Dongan Road, Shanghai, 200032, China. gongjing1990@163.com.
Shengdong NieSchool of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, 200093, China. nsd4647@163.com.ORCID 0000-0001-7825-4455

Funding

Key Program of National Natural Science Foundation of China No.81830052National Natural Science Foundation of China No. 82271989, 82071990 and 81571629Natural Science Foundation of Shanghai No. 21ZR1414200, 20ZR1438300Science and Technology Innovation Action Plan of Shanghai No. 18441900500Shanghai Key Laboratory of Molecular Imaging No. 18DZ2260400Soft Science Research Program of Zhejiang Provincial Department of Science and Technology No. 2022C35008Zhejiang Provincial Health Science and Technology Project No. 2021ky1215
6 · The paper itself

Abstract

This study aims to develop a CT-based hybrid deep learning network to predict pathological subtypes of early-stage lung adenocarcinoma by integrating residual network (ResNet) with Vision Transformer (ViT). A total of 1411 pathologically confirmed ground-glass nodules (GGNs) retrospectively collected from two centers were used as internal and external validation sets for model development. 3D ResNet and ViT were applied to investigate two deep learning frameworks to classify three subtypes of lung adenocarcinoma namely invasive adenocarcinoma (IAC), minimally invasive adenocarcinoma and adenocarcinoma in situ, respectively. To further improve the model performance, four Res-TransNet based models were proposed by integrating ResNet and ViT with different ensemble learning strategies. Two classification tasks involving predicting IAC from Non-IAC (Task1) and classifying three subtypes (Task2) were designed and conducted in this study. For Task 1, the optimal Res-TransNet model yielded area under the receiver operating characteristic curve (AUC) values of 0.986 and 0.933 on internal and external validation sets, which were significantly higher than that of ResNet and ViT models (p < 0.05). For Task 2, the optimal fusion model generated the accuracy and weighted F1 score of 68.3% and 66.1% on the external validation set. The experimental results demonstrate that Res-TransNet can significantly increase the classification performance compared with the two basic models and have the potential to assist radiologists in precision diagnosis.

Indexed as

Adenocarcinoma of LungDeep LearningImage Processing, Computer-AssistedLung NeoplasmsTomography, X-Ray ComputedComputer SimulationFemaleHumansMaleMiddle AgedRetrospective StudiesCT ImagesGround-glass NodulesHybrid Ensemble ModelLung AdenocarcinomaPathological Subtypes

Identifiers

PMID38861071
PMCPMC11612082

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.